Kalvista Pharmaceuticals
Price & Volume
Stats
See more52W Range | $9.23-$19 |
Market Cap | $797.1M |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $1.4M |
Revenue Growth (YoY) | 30.7% |
Gross Profit (12 Mos) | -$59.4M |
Diluted EPS | -$3.94 |
News
See moreYahoo Finance • 3 months ago
Citizens Touts KalVista Pharmaceuticals, Inc. (KALV) Growth Trajectory on EKTERLY Prospects
Yahoo Finance • 4 months ago
Here are the major earnings before the open Tuesday
Yahoo Finance • 4 months ago
KalVista Pharmaceuticals GAAP EPS of -$0.92, revenue of $13.69M
Yahoo Finance • 4 months ago
KalVista Pharmaceuticals Q3 2026 Earnings Preview
About
CEO | Mr. Benjamin L. Palleiko |
Address | 200 Crossing Boulevard, Framingham, MA, United States, 01702 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 270 |
